Economic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patients (Q37516892)

20 August 2017

1 reference

title

Economic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patients (English)

1 reference

20 August 2017

1 reference

Graham F Pineo

1

1 reference

PubMed ID

19520676

20 August 2017

Russell D Hull

series ordinal

2

1 reference

20 August 2017

10 June 2009

1 reference

Clinical and Applied Thrombosis-Hemostasis

20 August 2017

1 reference

20 August 2017

15

1 reference

20 August 2017

5

1 reference

20 August 2017

489-500

1 reference

Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?

20 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Economic Burden of Long-Term Complications of Deep Vein Thrombosis after Total Hip Replacement Surgery in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

A cost analysis of the treatment of patients with post-thrombotic syndrome in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Cost-effectiveness of enoxaparin as thromboprophylaxis in acutely ill medical patients in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Heparin-induced thrombocytopenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Delayed elimination of enoxaparine in patients with chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

A systematic review of the associations between dose regimens and medication compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Hospitals' compliance with prophylaxis guidelines for venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Thromboprophylaxis rates in US medical centers: success or failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

Cost-effectiveness of prolonged administration of a low molecular weight heparin for the prevention of deep venous thrombosis following total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609335910

21 January 2018

Identifiers

DOI

10.1177/1076029609335910

1 reference

release_7wktok5nmbg3fjhfismhrm6n4e

20 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7wktok5nmbg3fjhfismhrm6n4e

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

19520676

1 reference

PubMed ID

19520676